In the cancers of prostate, colon, lung, melanoma, and Ewing sarcoma, CAV1 has been shown to activate the RAS-ERK-MEK signalling and promote cancer progression50–54, demonstrating that in certain cancer tissue the role of CAV1 in this pathway is opposite as compared to mesothelial cells. This evidence concerns the gene CAV1 and cancer.